Journal of Experimental Medicine, Vol 161, 718-730, Copyright © 1985 by Rockefeller University Press

ARTICLES

Development of graft-vs.-host disease-like syndrome in cyclosporine- treated rats after syngeneic bone marrow transplantation. I. Development of cytotoxic T lymphocytes with apparent polyclonal anti-Ia specificity, including autoreactivity

AD Hess, L Horwitz, WE Beschorner and GW Santos

Lethally irradiated rats reconstituted with syngeneic bone marrow and treated with cyclosporine (CsA) for 40 d develop a graft-vs.-host disease-like syndrome (GVHD) after CsA therapy. We attempted to assess the development of autoreactivity in these animals. Results revealed that a majority of the animals with syngeneic GVHD develop autocytotoxic T lymphocytes of the OX8 phenotype. In addition to reactivity with self, these cells were capable of lysing appropriate target cells from a variety of different rat strains. The target antigens appeared to be class II major histocompatibility antigens, because lysis could be effectively blocked by an anti-Ia monoclonal antibody. Cold target inhibition studies indicated that one effector cell was capable of lysing various target cells, and provided evidence against a polyclonal activation of multiple anti-Ia-reactive cells. These results suggested that the anti-class II autoreactive cell associated with syngeneic GVHD either recognizes a common class II determinant ("public" epitope) shared by multiple strains of rats, or was polyspecific with respect to "private" class II determinants.
CiteULike    Complore    Connotea    Del.icio.us    Digg    Facebook    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

• Bryson, J. S., Jennings, C. D., Brandon, J. A., Perez, J., Caywood, B. E., Kaplan, A. M. (2007). Adoptive transfer of murine syngeneic graft-vs.-host disease by CD4+ T cells. J. Leukoc. Biol. 82: 1393-1400 [Abstract] [Full Text]  
• Miura, Y., Thoburn, C. J., Bright, E. C., Phelps, M. L., Shin, T., Matsui, E. C., Matsui, W. H., Arai, S., Fuchs, E. J., Vogelsang, G. B., Jones, R. J., Hess, A. D. (2004). Association of Foxp3 regulatory gene expression with graft-versus-host disease. Blood 104: 2187-2193 [Abstract] [Full Text]  
• Cimaz, R (2004). Any increased risk of autoimmune disease?. Lupus 13: 736-739 [Abstract]  
• Bryson, J. S., Zhang, L., Goes, S. W., Jennings, C. D., Caywood, B. E., Carlson, S. L., Kaplan, A. M. (2004). CD4+ T Cells Mediate Murine Syngeneic Graft-versus-Host Disease-Associated Colitis. J. Immunol. 172: 679-687 [Abstract] [Full Text]  
• Flanagan, D. M., Jennings, C. D., Goes, S. W., Caywood, B. E., Gross, R., Kaplan, A. M., Bryson, J. S. (2002). Nitric oxide participates in the intestinal pathology associated with murine syngeneic graft-versus-host disease. J. Leukoc. Biol. 72: 762-768 [Abstract] [Full Text]  
• Miura, Y., Thoburn, C. J., Bright, E. C., Chen, W., Nakao, S., Hess, A. D. (2002). Cytokine and chemokine profiles in autologous graft-versus-host disease (GVHD): interleukin 10 and interferon gamma may be critical mediators for the development of autologous GVHD. Blood 100: 2650-2658 [Abstract] [Full Text]  
• Miura, Y., Thoburn, C. J., Bright, E. C., Sommer, M., Lefell, S., Ueda, M., Nakao, S., Hess, A. D. (2001). Characterization of the T-cell repertoire in autologous graft-versus-host disease (GVHD): evidence for the involvement of antigen-driven T-cell response in the development of autologous GVHD. Blood 98: 868-876 [Abstract] [Full Text]  
• Weinberg, K., Blazar, B. R., Wagner, J. E., Agura, E., Hill, B. J., Smogorzewska, M., Koup, R. A., Betts, M. R., Collins, R. H., Douek, D. C. (2001). Factors affecting thymic function after allogeneic hematopoietic stem cell transplantation. Blood 97: 1458-1466 [Abstract] [Full Text]  
• Flanagan, D. L., Jennings, C. D., Bryson, J. S. (1999). Th1 Cytokines and NK Cells Participate in the Development of Murine Syngeneic Graft-Versus-Host Disease. J. Immunol. 163: 1170-1177 [Abstract] [Full Text]  
• Chen, W., Thoburn, C., Hess, A. D. (1998). Characterization of the Pathogenic Autoreactive T Cells in Cyclosporine-Induced Syngeneic Graft-Versus-Host Disease. J. Immunol. 161: 7040-7046 [Abstract] [Full Text]  
• Guillaume, T., Rubinstein, D. B., Symann, M. (1998). Immune Reconstitution and Immunotherapy After Autologous Hematopoietic Stem Cell Transplantation. Blood 92: 1471-1490 [Full Text]  
• Nakao, S., Takami, A., Takamatsu, H., Zeng, W., Sugimori, N., Yamazaki, H., Miura, Y., Ueda, M., Shiobara, S., Yoshioka, T., Kaneshige, T., Yasukawa, M., Matsuda, T. (1997). Isolation of a T-Cell Clone Showing HLA-DRB1*0405-Restricted Cytotoxicity for Hematopoietic Cells in a Patient With Aplastic Anemia. Blood 89: 3691-3699 [Abstract] [Full Text]  
• Hess, A. D., Bright, E. C., Thoburn, C., Vogelsang, G. B., Jones, R. J., Kennedy, M. J. (1997). Specificity of Effector T Lymphocytes in Autologous Graft-Versus-Host Disease: Role of the Major Histocompatibility Complex Class II Invariant Chain Peptide. Blood 89: 2203-2209 [Abstract] [Full Text]  
• Paller, A. S., Nelson, A., Steffen, L., Gottschalk, L., Kaizer, H. (1988). T-Lymphocyte Subsets in the Lesional Skin of Allogeneic and Autologous Bone Marrow Transplant Patients. Arch Dermatol 124: 1795-1801 [Abstract]  
• Hood, A. F., Vogelsang, G. B., Black, L. P., Farmer, E. R., Santos, G. W. (1987). Acute Graft-vs-Host Disease: Development Following Autologous and Syngeneic Bone Marrow Transplantation. Arch Dermatol 123: 745-750 [Abstract]  

Home | Help | Feedback | Subscriptions | Archive | Search

TABLE OF CONTENTS